PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Hospitals - Market size and forecast 2018-2023 • Clinical diagnostic laboratories - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • Americas - Market size and forecast 2018-2023 • EMEA - Market size and forecast 2018-2023 • APAC - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: MARKET TRENDS PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Danaher • QIAGEN • Quest Diagnostics • Siemens PART 13: APPENDIX • Research methodology • List of abbreviations Exhibit 01: Years in consideration Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: End-user - Market share 2018-2023 (%) Exhibit 19: Comparison by end-user Exhibit 20: Hospitals - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Hospitals - Year-over-year growth 2019-2023 (%) Exhibit 22: Clinical diagnostic laboratories - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Clinical diagnostic laboratories - Year-over-year growth 2019-2023 (%) Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 25: Others - Year-over-year growth 2019-2023 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Customer landscape Exhibit 28: Market share by geography 2018-2023 (%) Exhibit 29: Geographic comparison Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Americas - Year-over-year growth 2019-2023 (%) Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions) Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%) Exhibit 34: APAC - Market size and forecast 2018-2023 ($ millions) Exhibit 35: APAC - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Decision framework Exhibit 39: Impact of drivers and challenges Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Abbott - Vendor overview Exhibit 46: Abbott - Business segments Exhibit 47: Abbott - Organizational developments Exhibit 48: Abbott - Geographic focus Exhibit 49: Abbott - Segment focus Exhibit 50: Abbott - Key offerings Exhibit 51: Danaher - Vendor overview Exhibit 52: Danaher - Business segments Exhibit 53: Danaher - Organizational developments Exhibit 54: Danaher - Geographic focus Exhibit 55: Danaher - Segment focus Exhibit 56: Danaher - Key offerings Exhibit 57: QIAGEN - Vendor overview Exhibit 58: QIAGEN - Product segments Exhibit 59: QIAGEN - Organizational developments Exhibit 60: QIAGEN - Geographic focus Exhibit 61: QIAGEN - Segment focus Exhibit 62: QIAGEN - Key offerings Exhibit 63: Quest Diagnostics - Vendor overview Exhibit 64: Quest Diagnostics - Business segments Exhibit 65: Quest Diagnostics - Organizational developments Exhibit 66: Quest Diagnostics - Segment focus Exhibit 67: Quest Diagnostics - Key offerings Exhibit 68: Siemens - Vendor overview Exhibit 69: Siemens - Business segments Exhibit 70: Siemens - Organizational developments Exhibit 71: Siemens - Geographic focus Exhibit 72: Siemens - Segment focus Exhibit 73: Siemens - Key offerings Exhibit 74: Validation techniques employed for market sizing Exhibit 75: List of abbreviations    

Abbott Danaher QIAGEN Quest Diagnostics Siemens